Financials
- Market Capitalization 677.19 M
- Employee 113
- Founded 2009
- CEO N/A
- Website www.aurabiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00226DGM5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.1
ratio cours/chiffre d'affaires
49.59
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2622 | PRME Prime Medicine, Inc. - Common Stock | 3.60 USD | -9.77% | +16.88% | +15.38% | -38.25% | 652.96 M USD | ||
| 2636 | NVCT Nuvectis Pharma, Inc. - Common Stock | 19.79 USD | -6.30% | -5.45% | -14.88% | +226.57% | 644.79 M USD | ||
| 2644 | PHAR Pharming Group N.V. - ADS, each representing 10 | 9.56 USD | -2.35% | -2.15% | -11.32% | -34.39% | 670.81 M USD | ||
| 2646 | MDXG MiMedx Group, Inc - Common Stock | 4.78 USD | +2.36% | +4.37% | +5.29% | -27.36% | 696.74 M USD |